BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3476145)

  • 1. Serum neuron-specific enolase in children's cancer.
    Cooper EH; Pritchard J; Bailey CC; Ninane J
    Br J Cancer; 1987 Jul; 56(1):65-7. PubMed ID: 3476145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
    Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
    Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
    Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
    Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
    In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
    Tsuchida Y; Honna T; Iwanaka T; Saeki M; Taguchi N; Kaneko T; Koide R; Tsunematsu Y; Shimizu K; Makino S
    J Pediatr Surg; 1987 May; 22(5):419-24. PubMed ID: 3585664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.
    Ishiguro Y; Kato K; Shimizu A; Ito T; Nagaya M
    Clin Chim Acta; 1982 May; 121(2):173-80. PubMed ID: 7046994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
    Viallard JL; Tiget F; Hartmann O; Lemerle J; Demeocq F; Malpuech G; Dastugue B
    Cancer; 1988 Dec; 62(12):2546-53. PubMed ID: 3191453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical biochemistry of neuron specific enolase.
    Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
    Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
    Hashimoto K; Gotoh Y; Tada K
    Tohoku J Exp Med; 1986 May; 149(1):25-30. PubMed ID: 3738914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
    Isgrò MA; Bottoni P; Scatena R
    Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific enolase in neuroblastoma and other pediatric tumors: a comparative nude mouse and clinical investigation.
    Tsuchida Y; Yokota S; Bessho F; Yokomori K; Makino S; Saito S
    Tumour Biol; 1985; 6(1):67-73. PubMed ID: 4023563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-specific enolase as a differential marker in a case of retroperitoneal tumour.
    Läckgren G; Påhlman S; Esscher T; Olsen L; Grotte G
    Z Kinderchir; 1983 Aug; 38(4):247-8. PubMed ID: 6314696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines.
    Påhlman S; Esscher T; Nilsson K
    Lab Invest; 1986 May; 54(5):554-60. PubMed ID: 3009968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific enolase evaluation in patients with neuroblastoma.
    Massaron S; Seregni E; Luksch R; Casanova M; Botti C; Ferrari L; Martinetti A; Molteni SN; Bellani FF; Bombardieri E
    Tumour Biol; 1998; 19(4):261-8. PubMed ID: 9679736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neuron-specific enolase may be raised in children with Wilms' tumour.
    Pritchard J; Cooper EH; Hamilton S; Bailey CC; Ninane J
    Lancet; 1987 Jan; 1(8524):110. PubMed ID: 2879166
    [No Abstract]   [Full Text] [Related]  

  • 16. Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
    Ishiguro Y; Kato K; Ito T; Horisawa M; Nagaya M
    Gan; 1984 Jan; 75(1):53-60. PubMed ID: 6327451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase as a marker for neuroblastoma and small-cell carcinoma of the lung.
    Påhlman S; Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K
    Tumour Biol; 1984; 5(2):119-26. PubMed ID: 6095430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
    Cooper EH
    Biomed Pharmacother; 1985; 39(4):165-6. PubMed ID: 2998499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
    Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
    Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor.
    Odelstad L; Påhlman S; Läckgren G; Larsson E; Grotte G; Nilsson K
    J Pediatr Surg; 1982 Aug; 17(4):381-5. PubMed ID: 6288908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.